|
Campath vs ATG
The results of the trials for Campath as a first line of treatment for SAA were not encouraging. In fact, the Campath line was stopped because of the large percentage of deaths and non-responders.
http://ash.confex.com/ash/2010/webpr...aper32347.html
It is still considered an option for treatment for relapse or non-responders to H-ATG though.
__________________
58 yo female, dx 9/08, AA/hypo-MDS, subclinical PNH, ATG/CsA 12/08, partial response. small trisomy 6 clone, low-dose cyclosporine dependent
|